CDC-RFA-PS22-2211: Enhanced surveillance of persons with early and late HIV diagnosis to understand system and individual factors associated with new infection and delayed testing
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Centers for Disease Control - NCHHSTP notices from 2022.
Centers for Disease Control - NCHHSTP offered grants to state and local governments. It expected to make about 10 awards worth $8.0 million in total. Applications closed on April 26, 2022.
From the official notice on Grants.gov, last changed February 22, 2022. Checked November 7, 2026.
- Total funding$8.0 million
- Expected awards10
- Cost sharingNot required
- Funding typeCooperative Agreement
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| CDC-RFA-PS22-2202 | October 8, 2021 | Closed December 17, 2021 | Closed |
Key dates
| Posted | February 22, 2022 |
|---|---|
| Deadline | April 26, 2022 |
| Archived by Grants.gov | June 1, 2022 |
Who can apply
This opportunity was open to state and local governments.
- State governments
- County governments
- City or township governments
Eligible applicants for this NOFO include all US State health departments, the six local health departments with independent HIV surveillance programs (City of Chicago Department of Public Health, Houston Department of Health and Human Services, Los Angeles County Department of Public Health, City of Philadelphia Department of Public Health, New York City Department of Health and Mental Hygiene, and San Francisco Department of Public Health), the District of Columbia Department of Health, and the territorial health departments (Commonwealth of Puerto Rico, the U.S. Virgin Islands) or their Bona Fide Agents. This program is authorized under Section 318(b-c) of the Public Health Service Act [42 U.S.C. Section 247c(b-c)], as amended.
Is this a realistic fit?
- Most of the program's money (93% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
The purpose of this NOFO is to improve understanding of barriers and gaps in HIV prevention services that may lead to continued HIV transmission or delayed diagnosis of HIV. This NOFO will support enhanced surveillance of people diagnosed with HIV during the earliest and latest stages of infection (i.e., stages 0 and 3, respectively) to understand recent experiences with HIV prevention and testing services, as well as the system- and individual-level barriers that led to these failures in early diagnosis and prevention. Recipients of this NOFO will identify, locate, and recruit all persons diagnosed in the past year with stage 0 or stage 3 infection in their jurisdiction for participation in behavioral interviews conducted by a CDC contractor. Data collected will be used to inform HIV prevention and testing activities to ultimately reduce new HIV infections and increase early diagnosis among those newly infected.
Who has won Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance grants before
From fiscal 2021 to 2025, Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance (93.944) awarded $122 million across 81 grant awards, an average of $1.5 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| City of New York | New York | 3 | $8.8 million |
| County of Los Angeles | California | 3 | $6.7 million |
| California Department of Public Health | California | 4 | $6.6 million |
| City of Houston | Texas | 4 | $6.2 million |
| New Jersey Department of Health | New Jersey | 3 | $6.0 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-PS22-2211 still open?
No. It closed on April 26, 2022.
Who can apply for Enhanced surveillance of persons with early and late HIV diagnosis to understand system and individual factors associated with new infection and delayed testing?
Centers for Disease Control - NCHHSTP accepted applications from state and local governments. The notice adds further conditions, so read its eligibility section.
What is the deadline for Enhanced surveillance of persons with early and late HIV diagnosis to understand system and individual factors associated with new infection and delayed testing?
Closed April 26, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $8.0 million in total across about 10 awards.
Who has won Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance grants before?
The largest recipients over five fiscal years were City of New York, County of Los Angeles, California Department of Public Health. The program made 81 awards worth $122 million in that time.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)